GenEvolutioN enhances cytogenetic analysis with Fluorescence In Situ Hybridization (FISH), a powerful technique for detecting chromosomal abnormalities. By targeting telomere and centromere regions, our approach provides greater precision in identifying genetic damage, improving risk assessment for genotoxicity.

To optimize mutagenicity testing, GenEvolutioN has developed miniaturized Ames and Nano® Ames tests, allowing high-throughput analysis with minimal test substance requirements. This innovation enhances efficiency, sensitivity, and regulatory compliance, making it an ideal solution for early-stage screening and impurity characterization.

GenEvolutioN has optimized the Cell Transformation Assay (CTA) to identify non-genotoxic carcinogens, substances that promote cancer through indirect mechanisms. By combining high-throughput screening, fluorescence staining, and biomarker detection, our approach enables early and accurate risk assessment, improving regulatory decision-making.